Indian SME pharma firms see shift of orders from China; cost, quality concerns remain

Small and mid-sized Indian pharmaceutical firms are witnessing a shift in orders away from China. As Western buyers diversify their supply chains, India benefits from lower labor costs and local raw materials. However, some industry leaders caution about the heavy reliance on Chinese imports for essential components.